Bottles of Similac baby formula from Abbott Laboratories are visible in a shipment box, in Lafayette, California, May 13, 2022.
Shortages of baby formula were reported in early 2022. (Smith Collection/Gado/Getty Images) WASHINGTON - Abbott Laboratories is under investigation by the Food and Drug Administration (FDA) following a recent report of another baby’s death potentially connected to Abbott formula.
The baby died in January after consuming Abbott formula, and the FDA said in a release Wednesday they learned about the child’s death from a June 10 consumer complaint.
The agency did not say which Abbott formula the child consumed or if it was connected to the Abbott Laboratories plant shutdown in February. "The agency has initiated an investigation, given that the complaint referenced that the infant had consumed an Abbott product.